Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Protein profiling in urine for the diagnosis of bladder cancer.

Vlahou A, Giannopoulos A, Gregory BW, Manousakas T, Kondylis FI, Wilson LL, Schellhammer PF, Wright GL Jr, Semmes OJ.

Clin Chem. 2004 Aug;50(8):1438-41. No abstract available.

2.

Can a point-of-care urine protein assay monitor bladder cancer recurrence?

O'donnell MA.

Nat Clin Pract Oncol. 2006 Sep;3(9):482-3. No abstract available.

PMID:
16955086
3.

Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers.

Chen YT, Chen HW, Domanski D, Smith DS, Liang KH, Wu CC, Chen CL, Chung T, Chen MC, Chang YS, Parker CE, Borchers CH, Yu JS.

J Proteomics. 2012 Jun 27;75(12):3529-45. doi: 10.1016/j.jprot.2011.12.031. Epub 2012 Jan 3.

PMID:
22236518
4.

Towards a comprehensive database of proteins from the urine of patients with bladder cancer.

Rasmussen HH, Orntoft TF, Wolf H, Celis JE.

J Urol. 1996 Jun;155(6):2113-9.

PMID:
8618346
5.

Application of a novel protein chip mass spectrometry technology for the identification of bladder cancer-associated biomarkers.

Vlahou A, Schellhammer PF, Wright GL Jr.

Adv Exp Med Biol. 2003;539(Pt A):47-60. Review. No abstract available.

PMID:
15088895
6.

Comparison of nuclear matrix protein 22 and bladder tumor antigen in urine of patients with bladder cancer.

Abbate I, D'Introno A, Cardo G, Marano A, Addabbo L, Musci MD, Pagliarulo A, Correale M, Quaranta M.

Anticancer Res. 1998 Sep-Oct;18(5B):3803-5.

PMID:
9854500
7.

[Urine-based oncological diagnostic for bladder carcinoma: what is new?].

Rübben H.

Urologe A. 2009 Jun;48(6):597. doi: 10.1007/s00120-009-1987-3. German. No abstract available.

PMID:
19557463
8.

The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.

Siracusano S, Niccolini B, Knez R, Tiberio A, Benedetti E, Bonin S, Ciciliato S, Pappagallo GL, Belgrano E, Stanta G.

Eur Urol. 2005 Mar;47(3):327-33. Epub 2004 Dec 2.

PMID:
15716196
9.
10.

Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis.

Iwaki H, Kageyama S, Isono T, Wakabayashi Y, Okada Y, Yoshimura K, Terai A, Arai Y, Iwamura H, Kawakita M, Yoshiki T.

Cancer Sci. 2004 Dec;95(12):955-61.

11.

Current and emerging bladder cancer urinary biomarkers.

Parker J, Spiess PE.

ScientificWorldJournal. 2011 May 26;11:1103-12. doi: 10.1100/tsw.2011.104. Review.

12.

A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.

Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, Gao B, Wang W, Gu L, Meng J, Wang J, Feng X, Li Y, Yao X, Zhu J.

Clin Cancer Res. 2007 Dec 15;13(24):7296-304.

13.

Urinary fibronectin in diagnosis and follow-up of patients with urinary bladder cancer.

Malmström PU, Larsson A, Johansson S.

Br J Urol. 1993 Sep;72(3):307-10.

PMID:
8220992
14.

Evaluation of urinary proepithelin as a potential biomarker for bladder cancer detection and prognosis in Egyptian patients.

Selmy MA, Ibrahim GH, El Serafi TI, Ghobeish AA.

Cancer Biomark. 2010;7(3):163-70. doi: 10.3233/CBM-2010-0186.

PMID:
21263192
15.

Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer.

Sánchez-Carbayo M, Urrutia M, González de Buitrago JM, Navajo JA.

Clin Cancer Res. 2000 Sep;6(9):3585-94.

16.

Evaluation of a gas sensor array and pattern recognition for the identification of bladder cancer from urine headspace.

Weber CM, Cauchi M, Patel M, Bessant C, Turner C, Britton LE, Willis CM.

Analyst. 2011 Jan 21;136(2):359-64. doi: 10.1039/c0an00382d. Epub 2010 Oct 22.

PMID:
20967397
17.

New methods for detection of bladder cancer.

Grossman HB.

Semin Urol Oncol. 1998 Feb;16(1):17-22. Review.

PMID:
9508078
18.

Clinical study of urine NMP 22 (nuclear matrix protein 22) as a tumor marker in urinary epithelial cancer.

Takeuchi Y, Sawada Y, Yabuki D, Masuda E, Satou D, Kuroda K, Tajima M, Sawamura Y, Matsushima M.

Aktuelle Urol. 2003 Jul;34(4):265-6.

PMID:
14566681
19.

Can urinary biomarkers replace cystoscopic examination in bladder cancer surveillance?

Yutkin V, Nisman B, Pode D.

Expert Rev Anticancer Ther. 2010 Jun;10(6):787-90. doi: 10.1586/era.10.75. No abstract available.

PMID:
20553203
20.

Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine.

Kageyama S, Isono T, Iwaki H, Wakabayashi Y, Okada Y, Kontani K, Yoshimura K, Terai A, Arai Y, Yoshiki T.

Clin Chem. 2004 May;50(5):857-66. Epub 2004 Feb 5.

Supplemental Content

Support Center